March 15, 2018 / 11:38 AM / 2 years ago

BRIEF-Adaptimmune Announces Responses In Second Solid Tumor Indication

March 15 (Reuters) - Adaptimmune Therapeutics Plc:

* ADAPTIMMUNE ANNOUNCES RESPONSES IN SECOND SOLID TUMOR INDICATION WITH NY-ESO SPEAR T-CELLS

* ADAPTIMMUNE THERAPEUTICS - REPORTED 3 PARTIAL RESPONSES & 1 STABLE DISEASE IN FIRST 4 PATIENTS DOSED WITH NY-ESO SPEAR T-CELLS IN A SECOND SOLID TUMOR

* ADAPTIMMUNE THERAPEUTICS - TRANSITION OF NY-ESO SPEAR T-CELL THERAPY PROGRAM IS ONGOING GLAXOSMITHKLINE PLC Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below